Caracterizacion de pacientes hipertensos no controlados con Sindrome Metabolico .13
111. Kelly D, Wing R, Buonocore C, Sturis J, Polonsky K, Fitzimmons M. relative effects of calorie restriction and weight loss in noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 1993;77:1287-93.
112. Godpaster BH, Kelley DE, Wing RR, Meier A, Thaete FL. Effects of weight loss on regional fat distribution and insulin sensivity in obesity. Diabetes 1999;48:239-47.
113. Fernandes J, Martin K, Hutto AW, Dawkins CR, Newcomer BR. Relationships between insulin sensivity and intramyocellular lipid during short term very low calorie diet in obese type 2 diabetics. Diabetes 2003;52 (Suppl1):328.
114. Cervantes RM. Efecto de la dieta hipocalórica baja en carbohidratos sobre los niveles de cortisol en pacientes con síndrome metabólico. Tesis de especialidad en endocrinología. México, DF: IMSS-UNAM; 2004.
115. Daskalopoulous SS, Mikhailidis DP, Elisaf M. Prevention and treatment of the metabolic syndrome 2004; 55(6):598 American Association of Clinical Endocrinologist. Code for dismetabolic Syndrome X. Disponible en www.aace.com (consultado: 13/05/09)
116. Bertoni AG, Bonds DE, Goff Jr DC. Evaluación del manejo de las dislipidemias de acurdo con las guías del ATP III en EEUU. American Heart Journal 152(4):785-792 Oct 2006. Disponible en: http://www. amiif. org/ cms/ index.php? option= com_ content& task=view& id=251 &Itemid =41 (consultado: 25/04/2008)
117. Cheng, AYY, Fantus G. 2005. Oral antihyperglycemic therapy for type 2 diabetes mellitus. CMAJ; 172 (2): 213-26.
118. Roura Olmeda P, Mata Cases M, Cano Pérez JF. 2005. Nuevas perspectivas en el tratamiento de la diabetes mellitus. Aten Primaria; 35: 229-32.
119. Diabetes Control and Complications Trial Research Group: the effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329 : 977–986, 1993.
120. Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC, Lenfant C. Clinical management of Metabolic Syndrome: report of the American Heart Association/National Heart, Lung, and Blood Institute/American Diabetes Association conference on scientific issues related to management. Circulation 2004;109:552.